RAP2A and metabolic dysfunction-associated steatohepatitis: There are no published data on the association between the RAP2A coding gene and NAFLD spectrum; however, it has been reported that in hepatocellular carcinoma, RAP2A regulates MAP4K4, which leads to JNK and NF‐κB signalling activation which are the members of common molecular pathways of NASH pathogenesis.